Gimv - News

31/03/2020 - 14:40

Gimv EGM 12-05-2020 – COVID-19 update

26/03/2020 - 08:35

First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy

21/03/2020 - 11:10 Portefeuille

Summa uses its high-tech cutting machines to produce much-needed mouth masks #covid19

20/03/2020 - 07:30 Portefeuille

Ahead of expected further sector consolidation, Belgian wallpaper producer Grandeco expands its shareholder base, with Down2Earth replacing Gimv as majority shareholder

19/03/2020 - 11:30 Corporate news

'Wie nu goed schakelt, komt als eerste door de bocht' - Colonne Koen Dejonckheere dans le magazine Trends.

17/03/2020 - 09:25 Portefeuille

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

20/02/2020 - 17:50 Portefeuille

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

18/02/2020 - 11:44 Portefeuille

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

06/02/2020 - 18:24 Portefeuille

JenaValve Technology Closes USD 50 Million Financing

23/01/2020 - 11:39 Portefeuille

General Fusion Closes $65M of Series E Financing - Gimv contribue à la recherche d'une réponse pour un avenir énergétique décarboné

19/12/2019 - 09:22 Portefeuille

Topas Therapeutics annonce le premier patient inscrit dans le Trial de phase 1 avec TPM203 dans Pemphigus vulgaris

12/12/2019 - 09:00 Portefeuille

Cegeka reinforces international position by acquiring KPN Consulting

04/12/2019 - 06:45 Portefeuille

Imcheck Therapeutics lève 53 millions de dollars, Gimv renforce son investissement dans le domaine de l'immuno-oncologie

27/11/2019 - 10:27 Portefeuille

Soutenu par Gimv, le groupe Claire acquiert Ijinus et renforce ainsi son pôle de produits communicants

21/11/2019 - 07:00 Financier

Poursuite de la croissance et rendement du portefeuille toujours solide

29/10/2019 - 15:43 Portefeuille

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

14/10/2019 - 08:00 Portefeuille

Eric de Montgolfier nommé CEO d'Invest Europe

09/09/2019 - 16:50 Portefeuille

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

09/09/2019 - 13:46 Portefeuille

Equipe Zorgbedrijven envisage de reprendre la clinique ophtalmologique Heuvelrug

05/09/2019 - 08:00 Portefeuille

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

30/07/2019 - 08:00 Portefeuille

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Filtrer communiqués de presse:

Gimv EGM 12-05-2020 – COVID-19 update

First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy

Summa uses its high-tech cutting machines to produce much-needed mouth masks #covid19

Ahead of expected further sector consolidation, Belgian wallpaper producer Grandeco expands its shareholder base, with Down2Earth replacing Gimv as majority shareholder

'Wie nu goed schakelt, komt als eerste door de bocht' - Colonne Koen Dejonckheere dans le magazine Trends.

Décision soins de santé Equipe Zorgbedrijven - Coronavirus

Biotalys announces second closing Series C totaling €45m

Itineris is looking for 60 new employees to accelerate growth

Alro is nominated trendsgazelle ambassador for medium sized companies

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

JenaValve Technology Closes USD 50 Million Financing

General Fusion Closes $65M of Series E Financing - Gimv contribue à la recherche d'une réponse pour un avenir énergétique décarboné

Topas Therapeutics annonce le premier patient inscrit dans le Trial de phase 1 avec TPM203 dans Pemphigus vulgaris

Cegeka reinforces international position by acquiring KPN Consulting

Imcheck Therapeutics lève 53 millions de dollars, Gimv renforce son investissement dans le domaine de l'immuno-oncologie

Soutenu par Gimv, le groupe Claire acquiert Ijinus et renforce ainsi son pôle de produits communicants

Poursuite de la croissance et rendement du portefeuille toujours solide

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

Eric de Montgolfier nommé CEO d'Invest Europe

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

Equipe Zorgbedrijven envisage de reprendre la clinique ophtalmologique Heuvelrug

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.